The sales forecast for Non-Steroid Anti-inflammatory and Antirheumatic Medicine in Italy shows a declining trend from 2024 to 2028, with values decreasing from 136.9 million USD in 2024 to 118.4 million USD in 2028. This reflects a year-on-year decrease in sales, highlighting the market's potential contraction. In 2023, the sales were still higher as we're observing a consistent downward trajectory over the forecast period.
Future trends to watch for include emerging therapeutic alternatives, potential regulatory changes, and shifts in consumer demand towards more holistic or integrative medicine approaches, which could further impact market dynamics.
